omega-n-methylarginine has been researched along with Hypertension, Renal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dillon, MJ; Frend, A; Goonasekera, CD; Rees, DD; Shah, V; Woolard, P | 1 |
| Baylis, C; Mahaney, J; Wagner, L; Xiao, S | 1 |
2 other study(ies) available for omega-n-methylarginine and Hypertension, Renal
| Article | Year |
|---|---|
Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Topics: Adolescent; Animals; Arginine; Child; Endothelium, Vascular; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renal; Hypertension, Renovascular; In Vitro Techniques; Male; Mice; Muscle Contraction; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylephrine; Renin; Vasoconstrictor Agents | 1997 |
Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells.
Topics: Animals; Aorta; Arginine; Biological Transport; Capillaries; Cattle; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypertension, Renal; Kidney Failure, Chronic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Urea; Uremia | 2001 |